Company agrees to $35-million settlement over kidney transplant - WFMJ.com News weather sports for Youngstown-Warren Ohio

Company agrees to $35-million settlement over kidney transplant drug

Posted: Updated:
COLUMBUS, Ohio -

Ohio Attorney General Mike DeWine has announced that Ohio and 41 other attorneys general have reached a $35 million settlement to resolve allegations that Wyeth Pharmaceuticals Inc. unlawfully promoted Rapamune, a drug approved for use by kidney transplant patients. Pfizer Inc., the parent company of Wyeth, agrees to be bound by the settlement.

Ohio will receive $984,812 as part of the settlement.

Rapamune is currently approved by the U.S. Food and Drug Administration (FDA) to prevent the body from rejecting an organ after kidney transplant surgery.

The attorneys general allege that Wyeth violated state consumer protection laws by misrepresenting the uses and benefits of Rapamune, relating to: (1) unapproved use following an organ transplant other than a kidney transplant; (2) unapproved protocol of converting patients to Rapamune after they first received a different immunosuppressive drug; and (3) use in unapproved drug combinations.

Today's proposed settlement, which must be approved by the court, requires Pfizer to ensure that its marketing and promotional practices do not unlawfully promote Rapamune or any Pfizer product.

Specifically, Pfizer shall not:

Make, or cause to be made, any written or oral claim that is false, misleading, or deceptive regarding any Pfizer product;

Make any claim comparing the safety or effectiveness of a Pfizer product to another product when that claim is not supported by substantial evidence as defined by federal law and regulations;

Promote any Pfizer product for off-label uses;

Include mechanisms in its financial incentives to provide incentive compensation for sales that may be attributable to the off-label uses of any Pfizer product;

Affirmatively seek the inclusion of Rapamune in hospital protocols or standing orders unless Rapamune has been approved by the FDA for the indication for which it is to be included in the protocol or standing order;

Disseminate information describing any off-label or unapproved use of Rapamune unless such information and materials comply with applicable FDA regulations and the recommended actions in FDA Guidances for Industry; or

Seek to influence the prescribing of Rapamune in hospitals or transplant centers in any manner (including through funding clinical trials) that does not comply with the federal anti-kickback statute.

In Ohio, a complaint was filed and a proposed judgment order was submitted today to the Franklin County Common Pleas Court..

  • More From wfmj.comHot ClicksMore>>

  • 2 black men arrested at Starbucks get an apology from police

    2 black men arrested at Starbucks get an apology from police

    Friday, April 20 2018 1:05 AM EDT2018-04-20 05:05:13 GMT
    (AP Photo/Jacqueline Larma). In this Wednesday, April 18, 2018 photo, Rashon Nelson, left, and Donte Robinson, right, listen to a reporter's question during an interview with The Associated Press in Philadelphia. Their arrests at a local Starbucks quic...(AP Photo/Jacqueline Larma). In this Wednesday, April 18, 2018 photo, Rashon Nelson, left, and Donte Robinson, right, listen to a reporter's question during an interview with The Associated Press in Philadelphia. Their arrests at a local Starbucks quic...
    Two black men arrested at a Philadelphia Starbucks where they were waiting for a business meeting say they wonder how an everyday encounter could escalate into a police confrontation that left them fearing for...More >>
    Two black men arrested at a Philadelphia Starbucks where they were waiting for a business meeting say they wonder how an everyday encounter could escalate into a police confrontation that left them fearing for their lives.More >>
  • NASA's Tess spacecraft embarks on quest to find new planets

    NASA's Tess spacecraft embarks on quest to find new planets

    Thursday, April 19 2018 4:37 PM EDT2018-04-19 20:37:45 GMT
    (SpaceX via AP). This photo released by SpaceX on Wednesday, April 18, 2018 shows a Falcon 9 rocket carrying NASA's Transiting Exoplanet Survey Satellite at Cape Canaveral Air Force Station in Fla. Once in orbit, TESS will peer at hundreds of thousands...(SpaceX via AP). This photo released by SpaceX on Wednesday, April 18, 2018 shows a Falcon 9 rocket carrying NASA's Transiting Exoplanet Survey Satellite at Cape Canaveral Air Force Station in Fla. Once in orbit, TESS will peer at hundreds of thousands...
    NASA's newest planet-hunting spacecraft is back on the pad for another shot at launch.More >>
    NASA's newest planet-hunting spacecraft is back on the pad for another shot at launch.More >>
  • 'Fearless Girl' to leave Wall Street's 'Charging Bull'

    'Fearless Girl' to leave Wall Street's 'Charging Bull'

    Thursday, April 19 2018 4:36 PM EDT2018-04-19 20:36:43 GMT
    (AP Photo/Craig Ruttle, File). FILE - In this April 12, 2017 file photo, people gather at the "Fearless Girl" sculpture in lower Manhattan, New York. After she came to prominence staring down a symbol of Wall Street, a bronze bull at the foot of Broadw...(AP Photo/Craig Ruttle, File). FILE - In this April 12, 2017 file photo, people gather at the "Fearless Girl" sculpture in lower Manhattan, New York. After she came to prominence staring down a symbol of Wall Street, a bronze bull at the foot of Broadw...
    New York's 'Fearless Girl' statue that has become a global symbol of female can-do business power will be moved from her spot facing the Wall Street 'Charging Bull' to a location facing the New York Stock Exchange.More >>
    New York's 'Fearless Girl' statue that has become a global symbol of female can-do business power will be moved from her spot facing the Wall Street 'Charging Bull' to a location facing the New York Stock Exchange.More >>
Powered by Frankly
All content © Copyright 2000 - 2018 WFMJ. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms